We subsequently designed a far more specific probe, [18F]CFA, which was used in The existing research To guage dCK action in tumors when dealt with with a small molecule dCK inhibitor. This probe is usually getting studied inside a clinical trial at our institution To judge variations in dCK activity following most cancers immunotherapy eighteen. P